Cardiovascular drug therapy and surrogate COVID-19  outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors?

Polish Heart Journal (Kardiologia Polska)
Vol 79, No 9 (2021) Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the “miraculous” sodium-glucose co-transporter-2 inhibitors?

Vol 79, No 9 (2021)

Letter to the Editor

Published online: 2021-07-16

Page views 788

Article views/downloads 531

Get Citation

Connect on Social Media

Dimitrios Patoulias¹, Christodoulos Papadopoulos², George Kassimis³, Michael Doumas¹⁴

DOI: 10.33963/KP.a2021.0067

Pubmed: 34292565

Kardiol Pol 2021;79(9):1048-1049.

Not available

About Via Medica Advertising

Bookstore (Ikamed) TVMed

News